Cigna Group (NYSE:CI) Price Target Raised to $350.00

Cigna Group (NYSE:CIFree Report) had its price objective hoisted by Truist Financial from $320.00 to $350.00 in a report released on Tuesday, Marketbeat reports. The firm currently has a buy rating on the health services provider’s stock.

CI has been the topic of several other research reports. Sanford C. Bernstein restated a “market perform” rating and issued a $307.00 price target on shares of Cigna Group in a research note on Tuesday, January 6th. Barclays cut their target price on Cigna Group from $305.00 to $303.00 and set an “overweight” rating on the stock in a research note on Friday, February 6th. Leerink Partners lifted their price target on Cigna Group from $270.00 to $297.00 and gave the stock a “market perform” rating in a research report on Friday, February 6th. Morgan Stanley reissued an “overweight” rating and set a $355.00 price objective on shares of Cigna Group in a research report on Friday, October 31st. Finally, Zacks Research upgraded shares of Cigna Group from a “strong sell” rating to a “hold” rating in a research note on Monday, January 5th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $330.63.

Check Out Our Latest Stock Analysis on Cigna Group

Cigna Group Stock Performance

Shares of CI stock opened at $285.92 on Tuesday. The company’s fifty day moving average price is $278.79 and its 200-day moving average price is $284.00. The stock has a market cap of $76.38 billion, a PE ratio of 12.89, a price-to-earnings-growth ratio of 1.01 and a beta of 0.27. The company has a current ratio of 0.74, a quick ratio of 0.76 and a debt-to-equity ratio of 0.74. Cigna Group has a 12 month low of $239.51 and a 12 month high of $350.00.

Cigna Group (NYSE:CIGet Free Report) last issued its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The company had revenue of $72.50 billion during the quarter, compared to analysts’ expectations of $69.53 billion. During the same period last year, the company posted $6.64 EPS. Cigna Group’s revenue was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. On average, equities analysts expect that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th will be issued a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend is Thursday, March 5th. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s payout ratio is 27.23%.

Institutional Investors Weigh In On Cigna Group

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Compound Planning Inc. lifted its holdings in shares of Cigna Group by 2.7% during the 4th quarter. Compound Planning Inc. now owns 1,944 shares of the health services provider’s stock valued at $535,000 after buying an additional 51 shares during the period. Invesco Ltd. increased its position in Cigna Group by 27.4% during the fourth quarter. Invesco Ltd. now owns 2,421,775 shares of the health services provider’s stock valued at $666,545,000 after acquiring an additional 521,273 shares during the last quarter. Evansbrook LLC bought a new position in Cigna Group in the fourth quarter valued at about $361,000. Mercer Global Advisors Inc. ADV boosted its position in Cigna Group by 8.3% in the fourth quarter. Mercer Global Advisors Inc. ADV now owns 47,873 shares of the health services provider’s stock worth $13,176,000 after purchasing an additional 3,654 shares during the last quarter. Finally, Virtue Capital Management LLC bought a new stake in shares of Cigna Group during the 4th quarter valued at about $272,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

About Cigna Group

(Get Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Recommended Stories

Analyst Recommendations for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.